The shelf effectiveness removes the final procedural barrier for selling securityholders to flood the market with shares. Monitor for any 424B prospectus filings or pricing announcements, which would signal imminent share sales and further pressure the stock.
Price Chart
Executive Summary
The SEC declared effective Senti Biosciences' shelf registration statement on Form S-3 (File No. 333-296917) on September 24, 2026. This allows the company to offer and sell securities, including shares for resale by selling securityholders, at any time. The effectiveness creates a potential dilution overhang, particularly given the prior S-3/A filings that registered 25.6M shares (82.1% of outstanding) for resale by noteholders and 15.97M shares (51.2% of outstanding) for its largest stockholder, all tied to a going-private merger and the company's going-concern warning.
Key Facts
- Effectiveness date: September 24, 2026
- Registration statement: Form S-3, File No. 333-296917
- Prior S-3/A (Sept 22) registered 25,555,024 shares for resale by Celadon affiliate CPIF II-7 and NSG BioInnovation Fund, representing 82.1% of outstanding shares
- Prior S-3/A (Sept 10) registered 15,971,890 shares for resale by largest stockholder CPIF II-7 (Celadon affiliate), representing 51.2% of outstanding shares
- Company has a going-concern warning and an accumulated deficit of $375.5M
- Pending merger with a Celadon affiliate will divest the core business
Financial Impact
Potential dilution of up to 82.1% of outstanding shares from resale registrations, with the company in a precarious financial position and a going-concern warning
Risk Factors
- Massive dilution from resale of up to 82.1% of outstanding shares
- Company has a going-concern warning and minimal cash ($8.9M as of March 31, 2026)
- Pending merger with Celadon affiliate will divest core business, creating uncertainty for remaining public entity
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003050 |
| Document: 9999999995-26-003050-index.html | 9999999995-26-003050 |
| Document: 9999999995-26-003050.txt | 9999999995-26-003050 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $0.1720 | awaiting T+5 | — | $0.1750 (−1.74%) |
Oct 13, 2026 13d ago | DEFA14A | $0.2408 $0.2175 | ▼ −9.68% | ▼ −10.13% | $0.1750 (−27.33%) |
Oct 13, 2026 13d ago | 8-K | $0.2408 $0.2175 | ▲ +9.68% | ▲ +10.13% | $0.1750 (+27.33%) |
Sep 25, 2026 4w ago | EFFECT | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1750 (+46.86%) |
Sep 24, 2026 4w ago | DEFM14A | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1750 (+46.86%) |
Sep 22, 2026 4w ago | S-3/A | $0.3156 $0.3075 | ▲ +2.57% | ▲ +1.38% | $0.1750 (+44.55%) |
Sep 10, 2026 6w ago | S-3/A | $0.3060 $0.3200 | ▼ −4.58% | ▼ −4.80% | $0.1750 (+42.81%) |
Sep 4, 2026 7w ago | DEFA14A | $0.3326 $0.3021 | ▼ −9.17% | ▼ −7.96% | $0.1750 (−47.38%) |
Sep 4, 2026 7w ago | 8-K | $0.3326 $0.3021 | ▲ +9.17% | ▲ +7.96% | $0.1750 (+47.38%) |
Aug 20, 2026 9w ago | 8-K | $0.3886 $0.3770 | ▲ +2.99% | ▲ +3.46% | $0.1750 (+54.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers